Journal Information
Vol. 42. Issue S2.
Pages 117 (November 2020)
Download PDF
More article options
Vol. 42. Issue S2.
Pages 117 (November 2020)
DOI: 10.1016/j.htct.2020.10.197
Open Access
M.C. Cacemiroa, J.G. Cominala, L.L. Figueiredo-Pontesb, C.A. Sorgia, L.H. Facciolia, F.A. Castroa
a Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
b Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
Article information
Full Text

Arachidonic acid (AA)-derived lipid mediators like prostaglandins (PG), prostacyclins, thromboxanes (TX), leukotrienes (LT), and lipoxins (LX), are eicosanoids that act as key regulators of a wide variety of physiological responses and pathological processes. AA controls many important cellular processes, including cell proliferation, apoptosis, metabolism and migration. Eicosanoids seems to modulate hematopoiesis and stem cell function and stemness. Therefore, we decided to quantify eicosanoids levels in bone marrow plasma from myeloproliferative neoplasms patients and healthy subjects and to correlate the results with hematological parameters. Nine polycythemia vera (PV), ten essential thrombocythemia (ET) patients and eight healthy bone marrow donors (controls-CT) were investigated. Patients and controls were from Ribeirão Preto Medical School Hospital (HC-FMRP-USP), University of São Paulo, Ribeirão Preto, SP, Brazil. The CT group was composed of four males and four females at average age of 43 years. The PV group was composed of 5 males and 4 females at average age of 61 years and the ET group was composed of 1 male and 9 females at average age of 58 years. Plasma samples were obtained by centrifugation of bone marrow and used to measure the levels of eight lipid mediators (TXB2, 5-HETE, AA, 12-HETE, 11-HETE, 15-HETE, EPA, 15-OXO-ETE) by high performance liquid chromatography. The results showed higher production of 5-HETE by ET patients than CT group (p = 0.0058). For EPA, the highest production was observed in PV patients in comparison with ET (p = 0.0339) and CT (p = 0.0450). 11-HETE was higher in PV patients (p = 0.0464) compared to CT. Moreover, a mediator is considered important for a given group/disease when more than 50% of the individuals in that group are high producers for that mediator. The analysis of high and low producers showed that for the CT group none of the mediators can be considered important. In PV group, seven mediators (TXB2, 5-HETE, AA, 12-HETE, 11-HETE, EPA, 15-OXO-ETE) seem to play an important role in disease pathogenesis. In ET group, five mediators (5-HETE, 12-HETE, 11-HETE, 15-HETE, 15-OXO-ETE) were considered important. The correlation analysis between the levels of lipid mediators and hematological parameters showed in PV negative correlation between TXB2 and red blood cells count (p = 0.0429; r = -0.6167), 5-HETE and hematocrit (p = 0.0484; r = -0.6000), AA and hematocrit (p = 0.0150; r = -0.7311), 15-HETE and platelets count (p = 0.0429; r = -0.6167). There is also positive correlation between 15-OXO-TEE and hemoglobin (p = 0.0328; r = 0.6471). In ET there was positive correlation between 15-HETE levels and platelets count (p = 0.0075; r = 0.7576). The results suggest that the lipid mediators, analyzed here, play a role in oncoinflammatory process in myeloproliferative neoplasms. Keywords: Lipid mediators; Polycythemia vera; Essential thrombocythemia; Pathogenesis; Oncoinflammation. Funding: CAPES (Code 001), CNPq and FAPESP (2018-01756-5; 2018/19714-7).

Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter

Article options